CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 46 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,637,000 | -5.8% | 197,896 | -6.0% | 0.00% | 0.0% |
| Q3 2020 | $3,859,000 | +32.0% | 210,463 | +7.8% | 0.00% | 0.0% |
| Q2 2020 | $2,923,000 | +10.3% | 195,281 | +16.7% | 0.00% | 0.0% |
| Q1 2020 | $2,649,000 | -0.6% | 167,387 | +2.0% | 0.00% | 0.0% |
| Q4 2019 | $2,665,000 | +11.9% | 164,081 | +2.4% | 0.00% | 0.0% |
| Q3 2019 | $2,381,000 | -15.4% | 160,275 | -5.9% | 0.00% | 0.0% |
| Q2 2019 | $2,815,000 | +0.3% | 170,273 | +5.0% | 0.00% | 0.0% |
| Q1 2019 | $2,806,000 | -2.0% | 162,172 | +0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,863,000 | -4.0% | 162,102 | -1.3% | 0.00% | 0.0% |
| Q3 2018 | $2,982,000 | +86.6% | 164,315 | +101.0% | 0.00% | – |
| Q2 2018 | $1,598,000 | +139.6% | 81,758 | +115.3% | 0.00% | – |
| Q1 2018 | $667,000 | +92.2% | 37,980 | +22.9% | 0.00% | – |
| Q4 2017 | $347,000 | +8.4% | 30,904 | +2.9% | 0.00% | – |
| Q3 2017 | $320,000 | +21.7% | 30,036 | 0.0% | 0.00% | – |
| Q2 2017 | $263,000 | -83.2% | 30,036 | -77.3% | 0.00% | – |
| Q1 2017 | $1,563,000 | -10.5% | 132,483 | -0.6% | 0.00% | -100.0% |
| Q4 2016 | $1,746,000 | -11.2% | 133,312 | -1.7% | 0.00% | 0.0% |
| Q3 2016 | $1,966,000 | +21.4% | 135,559 | +0.4% | 0.00% | 0.0% |
| Q2 2016 | $1,619,000 | -26.4% | 135,066 | +14.5% | 0.00% | 0.0% |
| Q1 2016 | $2,200,000 | -9.4% | 117,985 | +4.4% | 0.00% | 0.0% |
| Q4 2015 | $2,427,000 | +28.3% | 112,968 | +1.1% | 0.00% | 0.0% |
| Q3 2015 | $1,891,000 | +92.0% | 111,731 | +325.6% | 0.00% | – |
| Q2 2015 | $985,000 | +232.8% | 26,251 | +178.7% | 0.00% | – |
| Q1 2015 | $296,000 | – | 9,419 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|